IV Compatibility Wall Charts
1 - 3
The King Guide to Parenteral Admixtures has provided the most up-to-date, complete and innovative injectable drug compatibility and stability information since 1971.
As a 'standard' reference in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
King Guide to Parenteral Admixtures
New for 2015
New and revised compatibility and stability data from 110 references
Over 1000 pages of updates that include:
We strive to include in King Guide to Parenteral Admixtures only that information that has been published in refereed journals or information that is provided by the manufacturer. We believe that by using only data that have been reviewed by peers via the professional literature, we insure the accuracy of the content of King Guide. So, for us, unpublished results that have not had the benefit of scholarly review is not adequate for us to use, and in our opinion other references that rely heavily upon unpublished results should give one cause for concern.
Exceeds JCAHO requirements
Over 2,600 primary source references
Includes the routes, dosages, temperatures, and containers used to determine compatibility and stability
Y-Site. Syringe, and other sets/container specific information
Extensive TPN/TNA data
The single largest cause of medication errors is incomplete information and potentially the most costly are those involving intravenous drug therapy. Immediate access to accurate, up-to-date, authoritative compatibility information is essential if such medication errors are to be avoided.
By providing the King Guide on a variety of media practitioners can quickly lookup compatibility and stability information where it matters most - at the point of care. There is a King Guide for every setting, often for less cost than a single improperly prepared admixture.
In this supplement we added one new drug monograph with stability and compatibility information for CABAZITAXEL.
In addition new compatibility information is reported for CISATRACURIUM BESYLATE with nine other drugs, DOXAPRAM HYDROCHLORIDE with twelve other drugs, in addition to compatibility reports for twenty-five different two-drug combinations.
Lastly, we added new stability information to these drug monographs: ASCORBIC ACID, BEVACIZUMAB, BORTEZOMIB, CEFTRIAXONE SODIUM, CISATRACURIUM BESYLATE, DAPTOMYCIN, DOCETAXEL, DOXAPRAM HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, EPOPROSTENOL SODIUM, ESMOLOL HYDROCHLORIDE, MEROPENEM, OMEPRAZOLE SODIUM, OXALIPLATIN, PROCAINAMIDE HYDROCHLORIDE, TREPROSTINIL SODIUM, and VASOPRESSIN.
© Copyright 2015 - King Guide Publications, Inc., PO Box 10317, Napa, CA 94581 - (p) 707-257-7573, (f) 707-257-7566